Related Experiment Videos
Ibrutinib and Rituximab in Waldenström's Macroglobulinemia
Adam J Olszewski1, Jorge J Castillo2
1Warren Alpert Medical School of Brown University, Providence, RI adam_olszewski@brown.edu
The New England Journal of Medicine
|November 16, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.
American journal of hematology·2026
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
Immunomodulatory effects of sea buckthorn leaf green tea in cyclophosphamide-induced immunosuppressed mice.
Food research international (Ottawa, Ont.)·2026
Does current research evidence indicate the need to conduct serum investigation(s) for ischaemic lesions in acute intracerebral haemorrhage work-up?
Cerebrovascular diseases (Basel, Switzerland)·2026
EXPRESS: Discrepancies in widely used serological methods to detect Borrelia infections may cause missed Lyme diagnoses.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026
First report of daratumumab interference in urine immunofixation electrophoresis confirmed by the HYDRASHIFT 2/4 Daratumumab assay.
Annals of clinical biochemistry·2026